AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
The Inflation Reduction Act and the Impact on Drug Prices
This chapter discusses the provisions of the Inflation Reduction Act related to pharmaceutical companies, including the provision allowing Medicare to negotiate drug prices. It explores the shortcomings of the current negotiation package and compares the US system to other countries where drug prices are negotiated based on effectiveness.